Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Trevi Therapeutics, Inc. (TRVI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -27.3-28.2-29.2-32.2-31.2-32.9-33.9-34.9
Depreciation and amortization   [+]0.00.00.00.00.00.00.00.1
Stock-based compensation    -1.3-1.4  0.02.5
Change in working capital   [+]  -0.5-0.7  0.0-0.2
Other operating activities  -4.00.72.76.26.55.15.01.0
Cash from operations  -33.0-29.3-28.2-28.1-26.7-28.5-28.9-31.6
   
Capital expenditures  0.30.20.20.00.00.00.00.0
Purchases of short-term investments, net  229.1263.6236.749.454.2   
Other cash from investing  -253.9-362.3-344.2 -108.4   
Cash from investing  -24.6-98.4-107.4-59.1-54.20.00.00.0
   
Repurchase of common stock, net    -51.851.2    
Option exercises  0.20.2 0.20.0 0.0 
Financing costs    0.0   0.0-0.1
Other cash from financing  98.6162.3163.373.469.316.020.87.6
Cash from financing  46.6110.2111.3124.469.216.020.87.7
   
Free cash flow  -32.7-29.1-28.0-28.1-26.7-28.5-28.9-31.6
        Per share (diluted)  ($0.40)($0.40)($0.50)($0.62)($0.79)($1.19)($1.38)($1.60)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy